Climedo
M├╝nchen
About Climedo
Climedo offers an all-in-one eCOA and EDC solution with hybrid capabilities for real-world and late-phase clinical studies. By using a patient-centric approach and leveraging real-time data insights and visualizations around a study’s current progress, Climedo empowers its clients to better engage with healthcare professionals and other key opinion leaders (KOLs). This boosts awareness, stimulates scientific dialogue and accelerates the launch success of new medical innovations, thus reaching more patients faster. Founded in Munich in 2017, Climedo is a leading trusted partner for pharma, medtech, CROs and academia with over 1.7 million patients enrolled to date. Learn more at www.climedo.com.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $7.0M
- Funding stage: Seed
- Last round: Seed (Feb 2022)
- Website: climedo.deen
- Phone: +49 89 32209394 0
Industries & Categories
Clinical Trials, Health Care, Medical, Pharmaceutical, Software
Social Profiles
Canonical: https://fsome.com/organization/climedo-92877 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.